Efficacy of COVID-19 vaccination in organized group: results of a prospective study

Author:

Stoma I. O.1,Korsak E. S.1,Voropaev E. V.1,Osipkina O. V.1,Kovalev A. A.1,Tumash O. L.1,Redko D. D.1

Affiliation:

1. Gomel State Medical University

Abstract

   Objective: to assess the efficacy of COVID-19 vaccination against in organized group.   Materials and methods: A total of 122 adults, employees of a higher education institution participated in the study. Study participants were observed prospectively and filled out a questionnaire where they indicated their age, presence of chronic diseases, history of COVID-19 and vaccination status.   Findings: the study participants were divided into two groups: 59 vaccinated (48.36 %) and 63 unvaccinated (51.64 %) individuals with no differences in age between the groups. There were significantly fewer confirmed cases of COVID-19 in the vaccinated group (р = 0,0008457, df = 1; χ2 = 11,138), significant differences (p = 0.0084; df = 4; χ2 =13.678) were observed in the number of cases among study participants based on their vaccination status.   Conclusion: participants diagnosed with pneumonia were 75 % unvaccinated (p = 0,00729; df = 1; χ2 = 7,2). All hospitalized study participants were unvaccinated (p = 0,004678; χ2 =8,0). None of the vaccinated participants needed respiratory support (p = 0,0455; df = 1; χ2 = 4,0). Chronic disease in vaccinated subjects made a significant (p = 0,04563; df = 2; χ2 = 6,1743) impact on COVID-19 severity.

Publisher

SPRIDA

Subject

Infectious Diseases

Reference18 articles.

1. Röltgen K., Nielsen S. C. A., Silva O., Younes S. F., Zaslavsky M., Costales C. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination // Cell. 2022. Vol. 185 № 6 P.1025-1040.e14. doi: 10.1016/j.cell.2022.01.018

2. Nka A. D., Ka’e A. C., Bouba Y., Ngoufack Jagni Semengue E., Tommo Tchouaket M. C., Takou D. et al. Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol // PLoS One. 2022 Vol. 17 № 8 P. e0272839. doi: 10.1371/journal.pone.0272839

3. Moghadas S.. M., Vilches T. N., Zhang K., Wells C. R., Shoukat A., Singer B. H., Meyers L. A., Neuzil K. M., Langley J. M., Fitzpatrick M. C., Galvani A. P. The impact of vaccination on COVID-19 outbreaks in the United States // medRxiv [Preprint]. 2021. Vol. 2. P. 2020. 11. 27. 2024 0051. doi: 10.1101/2020.11.27.20240051. Update in: Clinical Infectious Diseases. 2021. Vol. 16 № 73 (12) P. 2257-2264.

4. Nordström P., Ballin M., Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden // Lancet. 2022. Vol. 26 № 399 (10327). P. 814-823. doi: 10.1016/S0140-6736(22)00089-7.

5. Beeraka N. M, Sukocheva O. A., Lukina E., Liu J., Fan R. Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines // Reviews in Medical Virology. 2022. P. 13:e2346. Epub ahead of print. doi: 10.1002/rmv.2346.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3